Picture of BioMark Diagnostics logo

BUX BioMark Diagnostics Balance Sheet

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for BioMark Diagnostics, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.

2018
March 31st
2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
Period Length:
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Cash and Short Term Investments0.0370.020.6120.8780.383
Net Total Accounts Receivable
Net Total Receivables0.0130.0130.0160.0270.082
Prepaid Expenses
Total Current Assets0.050.0330.6280.9230.499
Net Property, Plant And Equipment0.0020.0020.0090.0270.969
Long Term Investments
Total Assets0.0520.0350.6370.9531.47
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities0.9521.251.080.9221.5
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities0.9521.251.081.032.11
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity-0.9-1.22-0.439-0.079-0.636
Total Liabilities & Shareholders' Equity0.0520.0350.6370.9531.47
Total Common Shares Outstanding

Or unlock with your email

Or unlock with your email